Medical weight management providers

Medical weight management is the category where regulatory change has moved fastest and where the distance between what is advertised and what is legal has been most consequential. Anything you read about compounded GLP-1 products that is more than a few months old should be treated as potentially out of date, including parts of this page — which is why every regulatory claim on this site carries a date and a source.

The category itself spans approved prescription medication managed by a clinician, compounded preparations sold through telehealth platforms, and programmes built mostly around coaching with a prescription attached. The clinical substance of these differs enormously, and so does the regulatory footing.

The distinction that matters most is between an FDA-approved product and a compounded one. Approved GLP-1 products have been through premarket review for a specific indication, and are dispensed as manufactured. A compounded preparation is made by a pharmacy and has not been reviewed by FDA for safety, effectiveness or quality. During the shortages of recent years, compounded versions were widely available under conditions that have since changed materially. A programme that was operating lawfully in one period may not be on the same footing now.

The added-ingredient question is worth understanding before you encounter it in a sales conversation. Compounded products combining a GLP-1 with something else — vitamin B12 is the common example — are sometimes presented as being outside the restriction on compounding copies of commercially available drugs. Whether that argument holds is a legal question with a specific statutory test behind it, not a marketing claim, and adding an ingredient does not automatically create a clinically meaningful difference for you.

What the directory records is which organisations advertise weight-management services, what they publish about their programmes, and whether they disclose the pharmacy involved. Pharmacy disclosure deserves particular attention in this category: if a programme supplies a compounded product, the identity of the compounder is a material fact about what you are receiving, and a clinic that will not name it has told you something.

Programme structure varies more than the medication does, and it is where most of the cost difference lives. Some programmes are a prescription and little else. Others include dietetic support, behavioural work, and regular clinical review. Both may be described as medically supervised. The phrase has no fixed meaning, so ask what supervision consists of in practice: who reviews your progress, how often, and whether you can reach a clinician between reviews without paying again.

Discontinuation is the part most likely to be glossed over at the point of sale. Weight regain after stopping GLP-1 therapy is well documented, and a programme that has not discussed what happens when you stop has not prepared you for the most likely outcome. Ask directly what the plan is if you discontinue, whether for cost, side effects, or supply. A clinic that treats that question as hypothetical is not being realistic about how these programmes usually end.

Supply is the other practical risk. Compounded products depend on a pharmacy relationship that can change, and the regulatory ground under compounded GLP-1s has moved repeatedly. A programme that cannot tell you what happens to your prescription if its compounder stops supplying, or if the regulatory position shifts again, is exposing you to an interruption you have no control over. That is a fair question to ask before you start rather than after.

One last point about how these programmes are sold. Introductory pricing, bundled first months and referral incentives are common, and they are designed to move you past the decision quickly. Nothing about weight management is urgent in the timescale of a sales call. Taking the written details away, checking what the medication actually is, and confirming who would be responsible for your care costs you a few days and protects you from the failure modes that matter most.